NCT05361707View on ClinicalTrials.gov

Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances

PHASE3RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 28, 2021

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
Autism Spectrum DisorderSleep DisorderNeurological DisorderSleep Disturbance
Interventions
DRUG

Tasimelteon Oral Capsule, Tasimelteon Liquid Suspension

Once Daily

Trial Locations (5)

10312

RECRUITING

Vanda Investigational Site, Staten Island

80301

RECRUITING

Vanda Investigational Site, Boulder

90404

RECRUITING

Vanda Investigational Site, Santa Monica

94578

RECRUITING

Vanda Investigational Site, San Leandro

95124

RECRUITING

Vanda Investigational Site, San Jose

Sponsors
All Listed Sponsors
lead

Vanda Pharmaceuticals

INDUSTRY